-
FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
First-cycle FDA review delivers one of the strongest signals yet that NRx's preservative-free ketamine opportunity may be entering its final stretch, while the company's broader neuropsychiatric pipeline continues to gain momentum.. Read more
-
Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
Today's Commercial Expansion, Growing Enterprise Deployments and Accelerating Merger Timeline Position MBody AI $MBAI to Capitalize on the Rapidly Emerging Multi-Trillion-Dollar Embodied AI Revolution. Read more
-
$40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
Leading Innovators in the Emerging AUV/Drone Sector Include ZenaTech (N A S D A Q: ZENA) $ZENA, Draganfly (N A S D A Q: DPRO) $DRPO, Quantum Cyber N.V. (N A S D A Q: QUCY) $QUCY, Unusual Machines, (N YS E American: UMAC) $UMAC, Safe Pro Group Inc. (N A S . Read more
-
$620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
Record financial performance, expanding European government partnerships, and an integrated technology platform position Circle8 Group $CIRC for its next phase of long-term growth.. Read more
-
AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
With 640% first-quarter revenue growth, a rapidly expanding Drone-as-a-Service platform, strategic acquisitions across North America, AI and quantum computing initiatives, and growing defense opportunities, ZenaTech $ZENA is executing an ambitious strateg. Read more
-
DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
Potential DARPA Award, FDA-Authorized Phase 2/3 Trial, Breakthrough Therapy NRX-101, and Robotic-Enabled TMS Platform Highlight Expanding Opportunities for NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP). Read more
-
NextBoat's AI-Powered Marine Marketplace Gains Momentum as Record Growth Signals an Inflection Point for Investors (N Y S E American: NXB)
Strategic partnerships, record second-quarter performance, expanding AI capabilities, and a clear path toward profitability position NextBoat as one of the more intriguing emerging technology stories in the recreational marine industry.. Read more
-
Is the Market Missing One of the Most Undervalued Cybersecurity Companies on the Stock Market? Cycurion, Inc. (N A S D A Q: CYCU):
With a Growing AI-Driven Cybersecurity Platform, $112 Million Contract Backlog, and Strategic Acquisitions, Cycurion $CYCU May Be Positioned for Significant Long-Term Growth. Read more
-
Billion-Dollar Scale Global Technology Powerhouse Being Built with Expanding Government Contracts: Circle8 Group (N A S D A Q: CIRC)
Following a transformational acquisition, record financial growth, and more than $600 million in recent public-sector contract awards, Circle8 Group $CIRC is positioning itself as a leading global technology and workforce solutions platform.. Read more
-
FIN Group Launches Reg Review: AI-Powered Compliance Platform for Investment Advisers, etc
WALNUT CREEK, Calif. - -- FIN Group Launches Reg Review — an AI-Powered Compliance Platform for Investment Advisers, Private Fund Managers, Exempt Reporting Advisers, and Broker-Dealers FIN Group announced the launch of Reg Review, an AI-powered.... Read more
-
Triple-Digit Growth, Stock Market Upgrade plus a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation (Stock Symbol: CDIX)
Twelve Surgical Centers, Strong Financial Momentum, And A Scalable Growth Strategy Position $CDIX For Its Next Phase Of Expansion. Read more
-
AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026
First Commercial Deployment of FDA-Cleared AI-Guided TMS Navigation System, Expanded FDA Pathway for NRX-101, and Growing Commercial Infrastructure Highlight Accelerating Momentum for NRx Pharmaceuticals (N A S D A Q: NRXP). Read more
-
Venezuela posts Single-Digit inflation for the first Time in 19 months
The Central Bank of Venezuela (BCV) reported that monthly inflation in May fell to 6.3%, the lowest level since October 2024 and the first single-digit reading of 2026. Acting President Delcy Rodriguez's administration is defending the bolívar through exc. Read more
-
$150+ Million Contracted Backlog, Strategic Acquisitions Adding Millions In Recurring Revenue, Improving Margins & A Clear Path Toward Profitability
Cycurion, Inc. (N A S D A Q: CYCU): Acquisitions of Halo Privacy, HavenX, Secuvant, plus Expanding Government Contracts, Strong Revenue Visibility, And Significant Operating Improvements Position Cycurion For Potential Multi-Year Growth. Read more
-
New analysis reveals second job workers keep just 80p in every pound they earn
Research by free financial tools site Accepted.co.uk has calculated what workers with a second job actually take home after tax, revealing that the typical second-job earner loses 20p in every pound to HMRC before they see a penny, with those pushed into . Read more
-
Grady Bay Capital Completes Acquisition of Brickhouse GPS
Establishes Connected-Vehicle and Fleet Telematics Software Platform Founder-CEO Todd Morris Continues to Lead; Platform Pursuing Active M&A Buy & Build Strategy. Read more
-
$97.9 Million Q1 Revenue Growth Reinforces Transformation Into a Global AI & Digital Services Powerhouse: IQSTEL, Inc. (N A S D A Q: IQST)
$IQST Delivering Nearly 70% Growth and Gross profit increased 7.8% to $2.08 million. Read more
-
FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
Expanding HOPE Therapeutics Network Positions NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP for Potential Breakout 2026 Growth. Read more
-
Greenwood Capital Relocates to MediaCityUK as Northern Business Demand Grows
SALFORD QUAYS, U.K. - -- Greenwood Capital, a UK business finance broker, has relocated its headquarters to MediaCityUK in Salford, citing strong demand from Northern businesses and the region's accelerating economic growth. The move, completed in.... Read more
-
Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
NRx Pharmaceuticals, Inc.Improved Financial Position, Commercial Ketamine Manufacturing, FDA Progress, and Expanding Neuroplastic Therapy Infrastructure Position $NRXP for a Potential Breakout Phase. Read more
-
Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
$CDIX Continues Scaling Its Orthopedic, Spine, and Pain Management Footprint as Revenue Growth, Margin Expansion, and Capital Markets Momentum Accelerate. Read more
Your online source of trusted news